Wednesday, April 15, 2020
Eyenuk Completes Contract In UK
Los Angeles-based artificial intelligence (AI) software developer Eyenuk said this morning that it has fulfilled a contract it had been awarded by Public Health England (PHE). The company's said its system--which is used for diabetic eye screening--has been used to grade 60,000 patient image sets from 6 different National Health Service (NHS) Diabetic Eye Screening Programmes in England. Eyenuk says its EyeArt AI Eye Screening System provides fully automated screening for diabetic retinopathy (DR), which is a leading cause of vision loss and a complication of diabetes.